SheMed News and Activities
Presence
SheMed provides digital healthcare services for women, with online consultations, treatment support, and health guidance. Its services target women seeking convenient, private, and accessible care in the United Kingdom.
SheMed products and services overview:
- Online consultations
- Womens health services
- Treatment support
- Health guidance
Revenue: ~$1 million
Employees: 12
Headquarters: London, United Kingdom (UK)
SheMed is one of the...
Acquisition, funding and merger involving SheMed.
- SheMed becomes a unicorn with its fundraising of $50 Million. (posted on November 18 2025).
Executives
View the org chart displaying its 6 main executives
Most searched biographies at SheMed
- Olivia Ferro, Co-Founder and Chief Executive Officer
- Rachael Joy, Chief Clinical and Strategy Officer
- Yashar Kutay, Head of HeMed
Create your alert
to follow the executive moves at SheMed.
Healthcare
SheMed has 3,578 competitors including UnitedHealth Group (United States (USA)), Kaiser Permanente (United States (USA)) and HCA (United States (USA)).
Popular M&A news in Healthcare
- Kardigan is now listed under ticker KARD. (posted on June 19 2026).
- Vizient has acquired Empierus (posted on June 12 2026).
- Novanta has announced the acquisition of Riverpoint Medical (posted on June 10 2026).
Popular contacts in Healthcare
News
Press releases by SheMed
- Wegovy Pill UK: MHRA Approves First Oral GLP-1 for Weight Loss | SheMed
- Is There a Wegovy Pill in the UK? | SheMed
- PCOS Is Now Called PMOS: What the Name Change Means for You | SheMed
- Personal fat threshold theory gives hope for type 2 diabetes remission
- American Diabetes Association Highlights Novel Agent Retatrutide which Results in Substantial Weight Reduction in People with Obesity or Type 2 Diabetes During Late Breaking Symposium | American Diabetes Association
- MHRA approves GLP –1 receptor agonist semaglutide to reduce risk of serious heart problems in obese or overweight adults
- MHRA smashes major illicit weight loss medicine production facility in record seizure
- Obesity and overweight
- New Insights into diabetes medications (GLP-1RAs) to treat mental ill health — Department of Psychiatry
- MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss
- View more press releases Close
Social media about SheMed
- SheMed on Wikipedia, Google News & Yahoo Finance
- SheMed on LinkedIn, X (Twitter) & YouTube
